De Geest K - Search Results

1

A Gynecologic Oncology Group phase II trial of the protein kinase C-beta inhibitor, enzastaurin and evaluation of markers with potential predictive and prognostic value in persistent or recurrent epithelial ovarian and primary peritoneal malignancies.

Usha L, Sill MW, Darcy KM, Benbrook DM, Hurteau JA, Michelin DP, Mannel RS, Hanjani P, De Geest K, Godwin AK. Usha L, et al. Among authors: de geest k. Gynecol Oncol. 2011 Jun 1;121(3):455-61. doi: 10.1016/j.ygyno.2011.02.013. Epub 2011 Mar 17. Gynecol Oncol. 2011. PMID: 21414654 Free PMC article. Clinical Trial.

2

Smoking, obesity, and survival in squamous cell carcinoma of the vulva.

Kirschner CV, Yordan EL, De Geest K, Wilbanks GD. Kirschner CV, et al. Among authors: de geest k. Gynecol Oncol. 1995 Jan;56(1):79-84. doi: 10.1006/gyno.1995.1013. Gynecol Oncol. 1995. PMID: 7821852

3

Salvage mitomycin/5-fluorouracil after platinum-based therapy for women with advanced ovarian cancer and related gynecologic malignancies.

Massad LS, Wagley E, Winkelman L, Lincoln S, Yordan EL, de Geest K, Wilbanks GD. Massad LS, et al. Among authors: de geest k. Eur J Gynaecol Oncol. 1994;15(5):337-42. Eur J Gynaecol Oncol. 1994. PMID: 7828601

4

Prognostic indicators of survival in advanced endometrial cancer.

Behbakht K, Yordan EL, Casey C, DeGeest K, Massad LS, Kirschner CV, Wilbanks GD. Behbakht K, et al. Gynecol Oncol. 1994 Dec;55(3 Pt 1):363-7. doi: 10.1006/gyno.1994.1307. Gynecol Oncol. 1994. PMID: 7835775

5

Differential response of cervical intraepithelial and cervical carcinoma cell lines to transforming growth factor-beta 1.

De Geest K, Bergman CA, Turyk ME, Frank BS, Wilbanks GD. De Geest K, et al. Gynecol Oncol. 1994 Dec;55(3 Pt 1):376-85. doi: 10.1006/gyno.1994.1310. Gynecol Oncol. 1994. PMID: 7835777

6

All-trans-retinoic acid inhibits the proliferation of cell lines derived from human cervical neoplasia.

Behbakht K, DeGeest K, Turyk ME, Wilbanks GD. Behbakht K, et al. Gynecol Oncol. 1996 Apr;61(1):31-9. doi: 10.1006/gyno.1996.0092. Gynecol Oncol. 1996. PMID: 8626114 Free article.

7

Intraperitoneal interferon-alpha in residual ovarian carcinoma: a phase II gynecologic oncology group study.

Berek JS, Markman M, Stonebraker B, Lentz SS, Adelson MD, DeGeest K, Moore D. Berek JS, et al. Gynecol Oncol. 1999 Oct;75(1):10-4. doi: 10.1006/gyno.1999.5532. Gynecol Oncol. 1999. PMID: 10502418 Clinical Trial.

8

Lack of efficacy of 24-h infusional topotecan in platinum-refractory ovarian cancer: A Gynecologic Oncology Group trial.

Markman M, Blessing JA, DeGeest K, Morgan M, Look KY, Herzog TJ, Rose PG. Markman M, et al. Gynecol Oncol. 1999 Dec;75(3):444-6. doi: 10.1006/gyno.1999.5640. Gynecol Oncol. 1999. PMID: 10600304 Clinical Trial.

9

Paclitaxel in the treatment of carcinosarcoma of the uterus: a gynecologic oncology group study.

Curtin JP, Blessing JA, Soper JT, DeGeest K. Curtin JP, et al. Gynecol Oncol. 2001 Nov;83(2):268-70. doi: 10.1006/gyno.2001.6256. Gynecol Oncol. 2001. PMID: 11606082 Clinical Trial.

10

Simultaneously detected endometrial and ovarian carcinomas--a prospective clinicopathologic study of 74 cases: a gynecologic oncology group study.

Zaino R, Whitney C, Brady MF, DeGeest K, Burger RA, Buller RE. Zaino R, et al. Gynecol Oncol. 2001 Nov;83(2):355-62. doi: 10.1006/gyno.2001.6400. Gynecol Oncol. 2001. PMID: 11606097

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters